Cargando…

Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy

Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Werner, Ries, Elena, Koderer, Corinna, Völter, Maximilian Friedrich, Wünsch, Anna Chiara, El-Mesery, Mohamed, Frackmann, Kyra, Kübler, Alexander Christian, Linz, Christian, Seher, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583874/
https://www.ncbi.nlm.nih.gov/pubmed/34769059
http://dx.doi.org/10.3390/ijms222111630
_version_ 1784597309041934336
author Schmitz, Werner
Ries, Elena
Koderer, Corinna
Völter, Maximilian Friedrich
Wünsch, Anna Chiara
El-Mesery, Mohamed
Frackmann, Kyra
Kübler, Alexander Christian
Linz, Christian
Seher, Axel
author_facet Schmitz, Werner
Ries, Elena
Koderer, Corinna
Völter, Maximilian Friedrich
Wünsch, Anna Chiara
El-Mesery, Mohamed
Frackmann, Kyra
Kübler, Alexander Christian
Linz, Christian
Seher, Axel
author_sort Schmitz, Werner
collection PubMed
description Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level.
format Online
Article
Text
id pubmed-8583874
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85838742021-11-12 Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy Schmitz, Werner Ries, Elena Koderer, Corinna Völter, Maximilian Friedrich Wünsch, Anna Chiara El-Mesery, Mohamed Frackmann, Kyra Kübler, Alexander Christian Linz, Christian Seher, Axel Int J Mol Sci Article Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level. MDPI 2021-10-27 /pmc/articles/PMC8583874/ /pubmed/34769059 http://dx.doi.org/10.3390/ijms222111630 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schmitz, Werner
Ries, Elena
Koderer, Corinna
Völter, Maximilian Friedrich
Wünsch, Anna Chiara
El-Mesery, Mohamed
Frackmann, Kyra
Kübler, Alexander Christian
Linz, Christian
Seher, Axel
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_full Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_fullStr Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_full_unstemmed Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_short Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
title_sort cysteine restriction in murine l929 fibroblasts as an alternative strategy to methionine restriction in cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583874/
https://www.ncbi.nlm.nih.gov/pubmed/34769059
http://dx.doi.org/10.3390/ijms222111630
work_keys_str_mv AT schmitzwerner cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT rieselena cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT koderercorinna cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT voltermaximilianfriedrich cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT wunschannachiara cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT elmeserymohamed cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT frackmannkyra cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT kubleralexanderchristian cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT linzchristian cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy
AT seheraxel cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy